The company, which is developing ozone injection technology to treat herniated discs, also recently completed a $520,000 angel financing to pursue certification of its spinal injection system.
Last year, the Minimus raised $1 million from 25 investors.
More Articles on Devices:
Bioventus Leases $5M Office, Creates 44 Jobs
Study: Novel Spine Device Can Improve Osteogenesis Imperfecta
Stryker to Eliminate 1,000 Employees by Year’s End
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
